What changed
West Pharmaceutical Services terminated its 2019 Credit Agreement on October 26, 2026, using proceeds from a new credit agreement to prepay $130.0 million in aggregate principal outstanding, which was repaid in full. The company incurred no early termination penalties in connection with the termination. The move refinances existing debt under the new credit facility.
Why it matters
West Pharmaceutical Services terminated its 2019 Credit Agreement on October 26, 2026, using proceeds from a new credit agreement to prepay $130.0 million in aggregate principal outstanding, which was